As of November 10, 2026, Inogen Inc is a publicly traded company (Nasdaq: INGN); its largest reported holder is BlackRock, with 6.2% on Schedule 13G/A of July 17, 2025. The largest insider holding is Smith Kevin Raymond Merrill, the chief executive and president, with 134,962 shares (0.52% of shares outstanding), per Form 4 of September 3, 2026 (Schedule 13G/A, July 17, 2025).
Is this your company?
About to sign with, pay or invest in Inogen Inc? See the free Snapshot first.
Free to see. No signup.
Is Inogen Inc a real, registered company?
- Inogen Inc files with the SEC under CIK 1294133 (its SEC filings).
- Its shares are listed under the ticker INGN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Beverly, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Inogen Inc in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Vafa Jamali (Form 8-K filed 2026-04-06). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2025-07-17).
Who are Inogen Inc's owners and officers?
Inogen Inc: incorporated in Delaware; business address in Beverly, Massachusetts; industry Orthopedic, Prosthetic & Surgical Appliances & Supplies (Form 8-K, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-07-17 | Blackrock, Inc. | 6.2% |
Questions about who owns Inogen Inc
Who owns Inogen Inc?
On this page, one holder's latest ownership filing reports 5% or more of Inogen Inc: Blackrock, Inc. (6.2%, Schedule 13G/A, filed 2025-07-17).
When did Blackrock, Inc. buy into Inogen Inc?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2025-07-17, reporting 6.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Inogen Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Inogen Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Inogen Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-06 | Vafa Jamali | appointed | ||
| Form 8-K, 2026-03-30 | Jason Richardson | Chief Financial Officer | appointed | 2026-04-06 |
| Form 8-K, 2026-03-30 | Michael Bourque | Chief Financial Officer | departed |
Which insiders own Inogen Inc shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 134,962 shares (0.52% of shares outstanding) (Form 4, 2026-09-03).
- , a director: 116,282 shares (0.45% of shares outstanding) (Form 4, 2026-06-09).
- , a director: 107,261 shares (0.41% of shares outstanding) (Form 4, 2026-06-09).
- , a director: 104,966 shares (0.40% of shares outstanding) (Form 4, 2026-06-09).
- , a director: 104,966 shares (0.40% of shares outstanding) (Form 4, 2026-06-09).
Shares outstanding: 26,002,082 as of 2026-10-29, from the company's latest SEC cover page.
How much has Inogen Inc raised?
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-11-05).
Keep reading
More on Inogen Inc and the records around it.
Inogen Inc elsewhere on the record
- Leadership changes Jul 2026
Companies that share a holder
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/inogen